Research News and Research

RSS

JDR paper shows no link between fluoride bone levels and osteosarcoma

A paper in the Journal of Dental Research by dentist Chester Douglass and colleagues, "An Assessment of Bone Fluoride and Osteosarcoma," claims to show no association between fluoride bone levels and osteosarcoma, a form of bone cancer.

3 Aug 2011

Needle-free nanopatch vaccine delivery system

The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.

3 Aug 2011

GSK, NPS enter agreement to evaluate ronacaleret in new indications

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today reported that it has entered into a new agreement with GlaxoSmithKline (GSK), that terminates and replaces a prior collaborative research and license agreement between NPS and GSK from 1993, which focused on the discovery and development of small molecule antagonists of the calcium receptor that increase secretion of parathyroid hormone.

3 Aug 2011

Pfizer second-quarter revenues decrease 1% to $17.0 billion

Pfizer Inc. today reported financial results for second-quarter 2011. As a result of Pfizer's decision to sell the Capsugel business, all revenues and expenses related to Capsugel in all periods presented are reflected in a single line, Discontinued operations - net of tax.

3 Aug 2011

Roundup: Atlanta hospital facing questions about extending dialysis care to immigrants; Fla. to limit HMO choices for state workers

The agreement providing dialysis for immigrants who were former Grady patients expires at the end of August, and it's unclear what will happen next. ... Grady's financial situation has deteriorated recently, and its losses this year could reach $20 million or more. Meanwhile, the hospital continues to shoulder an enormous financial burden in caring for uninsured patients, including immigrants, providing more than $200 million in indigent care annually.

3 Aug 2011

Lipid nanocarriers in cancer diagnosis and therapy: New book

This book introduces fundamental principles of lipid nanocarriers science relevant to cancer therapy. The first in this field, it fills a need for an accurate, coherent and authoritative introduction to lipid nanocarriers focusing in cancer therapy; both because of the growing popularity of these modern drug delivery systems and also because of the emergent need of dealing with cancer treatment.

2 Aug 2011

Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders

Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.

2 Aug 2011

Smoking doubles risk of atrial fibrillation

Results from a large, United States based cohort study show that current smokers double their risk of developing atrial fibrillation (AF) compared to people who have never smoked, after more than 13 years of follow-up. The study, published in the August edition of HeartRhythm, the official journal of the Heart Rhythm Society, indicates a trend towards significantly lower risk of developing AF for those who quit smoking cigarettes versus those who continue to smoke.

2 Aug 2011

Gender-based violence associated with lifetime risk of mental illness and disability

Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.

2 Aug 2011

Sea Squirts found to have pacemaker cells similar to human heart

An international team of molecular scientists have discovered that star ascidians, also known as sea squirts, have pacemaker cells similar to that of the human heart. The research, published in the JEZ A: Ecological Genetics and Physiology, may offer a new insight into the early evolution of the heart as star ascidians are one of the closest related invertebrates to mammals.

2 Aug 2011

Exact Sciences second quarter total revenues decreases to $1.0 million

Exact Sciences Corp. today announced its financial results for the quarter ended June 30, 2011.

2 Aug 2011

Enrollment commences in St. Jude Medical's atrial fibrillation stroke prevention trial

St. Jude Medical, Inc., a global medical device company, today announced that the first patient was enrolled in the EAST (Early comprehensive Atrial fibrillation Stroke prevention Trial) clinical trial.

2 Aug 2011

ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010 and provided an update on corporate developments.

2 Aug 2011

Rigel reports net loss of $21.5 million for second quarter 2011

Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2011.

2 Aug 2011

PSI develops new breast cancer diagnostic method

The Paul Scherrer Institute (PSI) has developed a new breast cancer diagnostic method, and is now carrying out first tests on non-preserved human tissue in conjunction with the Kantonsspital Baden AG. This new method should be able to reveal structures that cannot be seen using conventional mammography. Standard procedures only determine the extent to which X-rays are attenuated by various tissue structures.

2 Aug 2011

BARDA awards contracts for development of drugs for radiation injury to the GI tract

The first two contracts for advanced development of drugs to treat gastrointestinal (GI) tract injuries associated with acute radiation syndrome were awarded today by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

2 Aug 2011

Akorn second quarter revenue grows 59% to $32.1 million

Akorn, Inc., a niche specialty pharmaceutical company, today reported financial results for the second quarter of 2011. The Company also separately announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat front-of-eye diseases.

2 Aug 2011

First Edition: August 2, 2011

Today's headlines reveal how some specific elements of the debt-ceiling deal might impact Medicare providers.

2 Aug 2011

Life becomes harder after settlements for on-the-job back injuries

Financial and domestic problems for workers -- particularly those who are African-American, have lower incomes, or are younger than 35 -- get progressively worse in the years after they have settled claims for painful, on-the-job back injuries, a new Saint Louis University study finds.

2 Aug 2011

Bioengineered spinal discs can prevent chronic back or neck pain

Every year, millions of people contend with lower back and neck discomfort. With intent to ease their pain, Cornell University engineers in Ithaca and doctors at the Weill Cornell Medical College in New York City have created a biologically based spinal implant that could someday spell relief for these countless sufferers.

2 Aug 2011